Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
70-Gene classifier for differentiation between paclitaxel- and docetaxel-sensitive breast cancers.
Naoi Y, Tanei T, Kishi K, Tsunashima R, Tominaga N, Baba Y, Nakayama T, Shimazu K, Kim SJ, Tamaki Y, Noguchi S.
Cancer Lett. 2012 Jan 28;314(2):206-12. Epub 2011 Oct 1.
Related citations
Epigenetic biomarkers in skin cancer.
Greenberg ES, Chong KK, Huynh KT, Tanaka R, Hoon DS.
Cancer Lett. 2012 Jan 27. [Epub ahead of print]
Bcl-2 family members: essential players in skin cancer.
Nys K, Agostinis P.
Cancer Lett. 2012 Jul 1;320(1):1-13. Epub 2012 Jan 25.
Hypoxia, stem cells and bone tumor.
Zeng W, Wan R, Zheng Y, Singh SR, Wei Y.
Cancer Lett. 2011 Dec 27;313(2):129-36. Epub 2011 Sep 29. Review.
Kaposi sarcoma-associated herpesvirus (KSHV) induces a functional tumor-associated phenotype for oral fibroblasts.
Dai L, Qin Z, Defee M, Toole BP, Kirkwood KL, Parsons C.
Cancer Lett. 2012 May 28;318(2):214-20. doi: 10.1016/j.canlet.2011.12.019. Epub 2011 Dec 17.
SNX-2112, an Hsp90 inhibitor, induces apoptosis and autophagy via degradation of Hsp90 client proteins in human melanoma A-375 cells.
Liu KS, Liu H, Qi JH, Liu QY, Liu Z, Xia M, Xing GW, Wang SX, Wang YF.
Cancer Lett. 2012 May 28;318(2):180-8. doi: 10.1016/j.canlet.2011.12.015. Epub 2011 Dec 17.
Neuromedin B receptor antagonist suppresses tumor angiogenesis and tumor growth in vitro and in vivo.
Park HJ, Kim SR, Kim MK, Choi KS, Jang HO, Yun I, Bae SK, Bae MK.
Cancer Lett. 2011 Dec 15;312(1):117-27. Epub 2011 Aug 22.
Inhibitors of mTOR overcome drug resistance from topoisomerase II inhibitors in solid tumors.
Gaur S, Chen L, Yang L, Wu X, Un F, Yen Y.
Cancer Lett. 2011 Dec 1;311(1):20-8. Epub 2011 Jun 29.
Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transition in MCF-7 cells.
Vergara D, Valente CM, Tinelli A, Siciliano C, Lorusso V, Acierno R, Giovinazzo G, Santino A, Storelli C, Maffia M.
Cancer Lett. 2011 Nov 1;310(1):1-8. Epub 2011 Jun 24.
Prostate derived ETS factor (PDEF): a putative tumor metastasis suppressor.
Steffan JJ, Koul HK.
Cancer Lett. 2011 Nov 1;310(1):109-17. Epub 2011 Jun 29. Review.
Inflammasomes as molecular mediators of inflammation and cancer: potential role in melanoma.
Dunn JH, Ellis LZ, Fujita M.
Cancer Lett. 2012 Jan 1;314(1):24-33. Epub 2011 Oct 12. Review.
Dual inhibition of (V600E)BRAF and the PI3K/AKT/mTOR pathway cooperates to induce apoptosis in melanoma cells through a MEK-independent mechanism.
Sánchez-Hernández I, Baquero P, Calleros L, Chiloeches A.
Cancer Lett. 2012 Jan 28;314(2):244-55. Epub 2011 Oct 8.
Smad7 acts as a negative regulator of the epidermal growth factor (EGF) signaling pathway in breast cancer cells.
Kim S, Han J, Lee SK, Koo M, Cho DH, Bae SY, Choi MY, Kim JS, Kim JH, Choe JH, Yang JH, Nam SJ, Lee JE.
Cancer Lett. 2012 Jan 28;314(2):147-54. Epub 2011 Sep 29.
Regulation of ADP-ribosylation factor 4 expression by small leucine zipper protein and involvement in breast cancer cell migration.
Jang SY, Jang SW, Ko J.
Cancer Lett. 2012 Jan 28;314(2):185-97. Epub 2011 Sep 29.
Calycosin promotes proliferation of estrogen receptor-positive cells via estrogen receptors and ERK1/2 activation in vitro and in vivo.
Chen J, Liu L, Hou R, Shao Z, Wu Y, Chen X, Zhou L.
Cancer Lett. 2011 Sep 28;308(2):144-51. Epub 2011 May 25.
Nitidine Chloride inhibits breast cancer cells migration and invasion by suppressing c-Src/FAK associated signaling pathway.
Pan X, Han H, Wang L, Yang L, Li R, Li Z, Liu J, Zhao Q, Qian M, Liu M, Du B.
Cancer Lett. 2011 Dec 27;313(2):181-91. Epub 2011 Sep 10.
Differential expression of microRNA expression in tamoxifen-sensitive MCF-7 versus tamoxifen-resistant LY2 human breast cancer cells.
Manavalan TT, Teng Y, Appana SN, Datta S, Kalbfleisch TS, Li Y, Klinge CM.
Cancer Lett. 2011 Dec 26;313(1):26-43. Epub 2011 Sep 10.
Inactivation of Rac1 reduces Trastuzumab resistance in PTEN deficient and insulin-like growth factor I receptor overexpressing human breast cancer SKBR3 cells.
Zhao Y, Wang Z, Jiang Y, Yang C.
Cancer Lett. 2011 Dec 26;313(1):54-63. Epub 2011 Sep 3.
TGFBI expression reduces in vitro and in vivo metastatic potential of lung and breast tumor cells.
Wen G, Partridge MA, Li B, Hong M, Liao W, Cheng SK, Zhao Y, Calaf GM, Liu T, Zhou J, Zhang Z, Hei TK.
Cancer Lett. 2011 Sep 1;308(1):23-32. Epub 2011 May 10.
Pegylated liposomal doxorubicin as first-line monotherapy in elderly women with locally advanced or metastatic breast cancer: novel treatment predictive factors identified.
Green H, Stål O, Bachmeier K, Bäcklund LM, Carlsson L, Hansen J, Lagerlund M, Norberg B, Franzén Å, Åleskog A, Malmström A.
Cancer Lett. 2011 Dec 27;313(2):145-53. Epub 2011 Aug 31.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on